• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
1.11% 8.9¢

IMMURON LIMITED

Market Cap $20.29M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMC
Bird flu 		11:00 15 2.6K
11:00 Last post  Cuprum29 Comments Created with Sketch.  15  Views Created with Sketch.  2.6K 
IMC
Ann: Board Change 		08/05/24 2 601
08/05/24 Last post  davide1 Comments Created with Sketch.  2  Views Created with Sketch.  601 
IMC
Banter and General Comments 		08/05/24 29 9.5K
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

Read More   right-arrow Created with Sketch.
AUQ
10 May 2024
ALARA RESOURCES LIMITED
08/05/24 Last post  Cornhulio Comments Created with Sketch.  29  Views Created with Sketch.  9.5K 
IMC
Ann: Final Director's Interest Notice (SA) 		03/05/24 0 204
03/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  204 
IMC
Company presenting on LIVE & FREE webinar TOMORROW (Tuesday) @ 10am AWST 		30/04/24 1 588
30/04/24 Last post  goolop27 Comments Created with Sketch.  1  Views Created with Sketch.  588 
IMC
Ann: Change in substantial holding 		30/04/24 1 414
30/04/24 Last post  ich Comments Created with Sketch.  1  Views Created with Sketch.  414 
IMC
Ann: Immuron CEO Steven Lydeamore to present at The Watchlist 		25/04/24 3 1.1K
25/04/24 Last post  goolop27 Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
IMC
Ann: Immuron to host Live Virtual Event 		15/04/24 0 323
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  323 

See All Discussions arrow Created with Sketch.

Timeline

Final Director's Interest Notice (SA)
03 May 14:26
 
Board Change
03 May 10:02
 
Change in substantial holding
30 Apr 08:23
 
Immuron CEO Steven Lydeamore to present at The Watchlist
23 Apr 09:17
 
Immuron to host Live Virtual Event
15 Apr 10:34
 
Immuron Travelan sales continued strong growth
10 Apr 09:00
 
View More arrow Created with Sketch.

Featured News

SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
360 Family tracking app Life360 eyeing a US IPO as profitability approaches
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
CMG Critical Minerals Group boosts JORC by 96% to 713Mt vanadium; others
right-arrow Created with Sketch.
(20min delay)
Last
8.9¢ 		Change
-0.001(1.11%) 		Mkt cap ! $20.29M
Open High Low Value Volume
9.0¢ 9.0¢ 8.4¢ $42.72K 484.4K

Buyers (Bids)

No. Vol. Price($)
1 27350 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 25714 2
View Market Depth
Last trade - 13.42pm 10/05/2024 (20 minute delay) ?
Last
8.9¢ 		  Change
-0.001 ( 3.26 %)
Open High Low Volume
8.7¢ 8.9¢ 8.7¢ 88447
Last updated 13.34pm 10/05/2024 ?
IMC (ASX) Chart

Top Stories

Recce breathes better on positive lung infection drug pilot test results

Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.

Featured News

RCE Recce breathes better on positive lung infection drug pilot test results
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
UNT UNITH's digital humans expand into Amazon; Facebook
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
360 Family tracking app Life360 eyeing a US IPO as profitability approaches
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.